XML 69 R54.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Certain Transactions - Other Transactions - Additional Information (Detail) $ in Millions |  |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jan. 08, 2018 USD ($) | Sep. 17, 2017 USD ($) | May 12, 2017 USD ($) | Mar. 03, 2016 USD ($) | Sep. 30, 2018 USD ($) | Dec. 31, 2016 USD ($) | Nov. 30, 2016 USD ($) | Sep. 30, 2016 USD ($) Lawsuit | Dec. 31, 2018 USD ($) | Mar. 31, 2018 USD ($) | Jun. 30, 2017 USD ($) | Dec. 31, 2018 USD ($) | Dec. 31, 2017 USD ($) | Dec. 31, 2016 USD ($) | Oct. 31, 2016 USD ($)
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill written off allocated to divested business |  |  |  |  |  |  |  |  |  |  |  | $ 79 | $ 697 |  |
Other asset impairments, restructuring and other items |  |  |  |  |  |  |  |  |  |  |  | 987 | 1,836 | $ 830 |
Net (gain) loss from sale of long-lived assets and investments |  |  |  |  |  |  |  |  |  |  |  | $ 19 | 1,090 | 764 |
Women Health [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill written off allocated to divested business |  |  |  |  |  |  |  |  |  |  |  |  | $ 329 |  |
CVC Capital Partners Fund VI [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net gain on sale of portfolio of products |  |  |  |  |  |  |  |  |  | $ 93 |  |  |  |  |
Transaction expenses for divestitures |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |
PGT Healthcare Partnership [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other asset impairments, restructuring and other items |  |  |  |  |  |  |  |  |  | 64 |  |  |  |  |
Write-down of investment |  |  |  |  |  |  |  |  |  | (94) |  |  |  |  |
Net (gain) loss from sale of long-lived assets and investments |  |  |  |  | $ 50 |  |  |  |  |  |  |  |  |  |
Women Health [Member] | CVC Capital Partners Fund VI [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale agreement with CVC capital partners fund VI |  | $ 703 |  |  |  |  |  |  |  |  |  |  |  |  |
Rimsa [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash consideration |  |  |  | $ 2,300 |  |  |  |  |  |  |  |  |  |  |
Number of lawsuits filed | Lawsuit |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |
Alder [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment | $ 25 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative agreement milestone payments | $ 175 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Otsuka [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  | $ 50 |  |  |  |  |  |  |  |  |  |  |  |
Attenukine [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  |  |  |  | $ 30 |  |  |  |  |  |  |  |  |
Additional considerations |  |  |  |  |  | $ 280 |  |  |  |  |  |  |  | $ 280 |
Ninlaro [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  |  |  |  |  | $ 150 |  |  |  |  |  |  |  |
Payment |  |  |  |  |  |  | $ 150 |  |  |  |  |  |  |  |
Celltrion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Refundable payment |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 60
Total associated cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 160
Regeneron [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  |  |  |  |  |  | $ 250 |  |  |  |  |  |  |
Collaborative agreement milestone payments |  |  |  |  |  |  |  |  | $ 60 | $ 35 | $ 25 |  |  |  |
Research and development costs |  |  |  |  |  |  |  | $ 1,000 |  |  |  |  |  |  |

X
- Definition Additional Considerations + References No definition available. + Details
Name: | teva_AdditionalConsiderations
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Additional Payments + References No definition available. + Details
Name: | teva_AdditionalPayments
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Collaborative Agreement Milestone Payments + References No definition available. + Details
Name: | teva_CollaborativeAgreementMilestonePayments
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Impairments restructuring and others. + References No definition available. + Details
Name: | teva_ImpairmentsRestructuringAndOthers
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number Of Lawsuits Filed + References No definition available. + Details
Name: | teva_NumberOfLawsuitsFiled
Namespace Prefix: | teva_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Profit from sale of long lived assets and investment. + References No definition available. + Details
Name: | teva_ProfitFromSaleOfLongLivedAssetsAndInvestment
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Refundable Payment + References No definition available. + Details
Name: | teva_RefundablePayment
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Research And Development Costs + References No definition available. + Details
Name: | teva_ResearchAndDevelopmentCosts
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total Associated Cost + References No definition available. + Details
Name: | teva_TotalAssociatedCost
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Transaction Costs Associatedwith Divestiture + References No definition available. + Details
Name: | teva_TransactionCostsAssociatedwithDivestiture
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront payments + References No definition available. + Details
Name: | teva_UpfrontPayments
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of realized and unrealized gain (loss) on investment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 10 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27405-111563 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(c),9(a)) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 + Details
Name: | us-gaap_GainLossOnInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 + Details
Name: | us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_NoncashOrPartNoncashAcquisitionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromSaleOfProductiveAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=teva_WomenHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=teva_CvcCapitalPartnersFundViMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=teva_PgtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_WomenHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=teva_CvcCapitalPartnersFundViMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_RimsaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_AlderMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_OtsukaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_AttenukineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_NinlaroMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_CelltrionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_RegeneronMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |